Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, but it requires buy-in from policy makers, biopharmaceutical firms ...

Despite their fundamental flaws, value assessment models are increasingly influencing the prices for medicines. Unless this centralized approach is rejected and replaced with a process that ...

Remember the buyer hierarchy The first step in assigning value to your customer list is to look at the big picture, keeping in mind the difference between customers and prospects. A house file will ...

Value assessment of new drugs and devices is gaining importance in the U.S. health care system. Pressure to do it right is accelerating.